Thrivent Financial for Lutherans’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20M Buy
213,994
+50,443
+31% +$4.72M 0.04% 369
2025
Q1
$17.3M Buy
163,551
+118,504
+263% +$12.5M 0.04% 428
2024
Q4
$4.36M Sell
45,047
-664
-1% -$64.2K 0.01% 972
2024
Q3
$4.52M Sell
45,711
-2,526
-5% -$250K 0.01% 969
2024
Q2
$4.15M Sell
48,237
-1,862
-4% -$160K 0.01% 969
2024
Q1
$3.8M Sell
50,099
-1,361
-3% -$103K 0.01% 1002
2023
Q4
$3.91M Sell
51,460
-1,264
-2% -$96K 0.01% 969
2023
Q3
$3.64M Sell
52,724
-2,276
-4% -$157K 0.01% 936
2023
Q2
$4.6M Sell
55,000
-2,902
-5% -$243K 0.01% 891
2023
Q1
$4.28M Sell
57,902
-1,978
-3% -$146K 0.01% 869
2022
Q4
$4.23M Sell
59,880
-20,849
-26% -$1.47M 0.01% 855
2022
Q3
$4.56M Buy
80,729
+8,560
+12% +$484K 0.01% 834
2022
Q2
$3.92M Buy
72,169
+30,804
+74% +$1.67M 0.01% 901
2022
Q1
$2.75M Buy
41,365
+13
+0% +$865 0.01% 1143
2021
Q4
$2.58M Buy
41,352
+416
+1% +$25.9K 0.01% 1227
2021
Q3
$2.94M Buy
40,936
+652
+2% +$46.8K 0.01% 1125
2021
Q2
$2.61M Buy
40,284
+25
+0.1% +$1.62K 0.01% 1247
2021
Q1
$2.41M Sell
40,259
-201
-0.5% -$12K 0.01% 1305
2020
Q4
$2.25M Sell
40,460
-26
-0.1% -$1.44K 0.01% 1246
2020
Q3
$1.76M Sell
40,486
-5,871
-13% -$255K ﹤0.01% 1223
2020
Q2
$2.12M Buy
46,357
+87
+0.2% +$3.97K 0.01% 1027
2020
Q1
$1.45M Buy
46,270
+2,310
+5% +$72.2K 0.01% 1108
2019
Q4
$1.37M Sell
43,960
-18
-0% -$562 ﹤0.01% 1257
2019
Q3
$1.34M Sell
43,978
-156,488
-78% -$4.77M ﹤0.01% 1212
2019
Q2
$11.9M Buy
200,466
+3,116
+2% +$186K 0.04% 465
2019
Q1
$12.2M Buy
197,350
+22,704
+13% +$1.4M 0.04% 436
2018
Q4
$9.75M Buy
174,646
+8,541
+5% +$477K 0.04% 455
2018
Q3
$10.2M Buy
166,105
+131,522
+380% +$8.08M 0.03% 489
2018
Q2
$1.77M Buy
34,583
+765
+2% +$39.2K 0.01% 961
2018
Q1
$1.53M Buy
33,818
+2,618
+8% +$119K 0.01% 1020
2017
Q4
$1.35M Buy
31,200
+615
+2% +$26.6K ﹤0.01% 1097
2017
Q3
$1.3M Buy
30,585
+300
+1% +$12.7K ﹤0.01% 1039
2017
Q2
$1.16M Buy
30,285
+1,770
+6% +$67.5K ﹤0.01% 1044
2017
Q1
$824K Buy
28,515
+4,400
+18% +$127K ﹤0.01% 1280
2016
Q4
$639K Buy
24,115
+1,530
+7% +$40.5K ﹤0.01% 1388
2016
Q3
$549K Buy
22,585
+900
+4% +$21.9K ﹤0.01% 1415
2016
Q2
$430K Buy
21,685
+1,400
+7% +$27.8K ﹤0.01% 1487
2016
Q1
$375K Buy
20,285
+1,190
+6% +$22K ﹤0.01% 1506
2015
Q4
$355K Buy
19,095
+820
+4% +$15.2K ﹤0.01% 1507
2015
Q3
$437K Buy
18,275
+1,200
+7% +$28.7K ﹤0.01% 1266
2015
Q2
$368K Buy
17,075
+1,100
+7% +$23.7K ﹤0.01% 1294
2015
Q1
$308K Buy
15,975
+100
+0.6% +$1.93K ﹤0.01% 1368
2014
Q4
$275K Buy
15,875
+300
+2% +$5.2K ﹤0.01% 1432
2014
Q3
$185K Buy
15,575
+650
+4% +$7.72K ﹤0.01% 1617
2014
Q2
$225K Buy
14,925
+100
+0.7% +$1.51K ﹤0.01% 1560
2014
Q1
$212K Buy
14,825
+50
+0.3% +$715 ﹤0.01% 1441
2013
Q4
$233K Buy
14,775
+100
+0.7% +$1.58K ﹤0.01% 1402
2013
Q3
$178K Buy
14,675
+100
+0.7% +$1.21K ﹤0.01% 1463
2013
Q2
$163 Buy
+14,575
New +$163 ﹤0.01% 1477